z-logo
open-access-imgOpen Access
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Author(s) -
Kandice R. Levental,
Hongmei Yu,
Laura Kass,
Johnathon N. Lakins,
Mikala Egeblad,
Janine T. Erler,
Sheri F T Fong,
Katalin Csiszár,
Amato J. Giaccia,
Wolfgang Weninger,
Mitsuo Yamauchi,
David L. Gasser,
Valerie M. Weaver
Publication year - 2009
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2009.10.027
Subject(s) - focal adhesion , extracellular matrix , lysyl oxidase , integrin , biology , microbiology and biotechnology , fibrosis , signal transduction , cancer research , pathology , carcinogenesis , cancer , medicine , cell , biochemistry , genetics
Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ECM remodeling to cancer is appreciated; the relevance of stiffening is less clear. We found that breast tumorigenesis is accompanied by collagen crosslinking, ECM stiffening, and increased focal adhesions. Induction of collagen crosslinking stiffened the ECM, promoted focal adhesions, enhanced PI3 kinase (PI3K) activity, and induced the invasion of an oncogene-initiated epithelium. Inhibition of integrin signaling repressed the invasion of a premalignant epithelium into a stiffened, crosslinked ECM and forced integrin clustering promoted focal adhesions, enhanced PI3K signaling, and induced the invasion of a premalignant epithelium. Consistently, reduction of lysyl oxidase-mediated collagen crosslinking prevented MMTV-Neu-induced fibrosis, decreased focal adhesions and PI3K activity, impeded malignancy, and lowered tumor incidence. These data show how collagen crosslinking can modulate tissue fibrosis and stiffness to force focal adhesions, growth factor signaling and breast malignancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom